Scarica l'app Stockscreener
8.43
2.55%
0.21
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RXST Giù?
Forum
Previsione
Rxsight Inc Borsa (RXST) Ultime notizie
Bragar Eagel & Squire, P.C. Reminds Investors of Class - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors of Class Actions Against Neogen, Alto, RxSight, and Replimune and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in RxSight, Inc. of Class Action Lawsuit and Upcoming DeadlinesRXST - cnhinews.com
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight - GlobeNewswire
What high frequency data says about RxSight Inc.Quarterly Portfolio Summary & Expert Curated Trade Setup Alerts - Newser
Class Action Filed Against RxSight, Inc. (RXST) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
Deadline Alert: RxSight, Inc. (RXST) Investors Who Lost - GlobeNewswire
DEADLINE ALERT for RXST, RMHIX, FI, and FLYW: The Law - GlobeNewswire
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of RxSight, Inc. (RXST) Shareholders - PR Newswire
Faruqi & Faruqi Reminds RxSight Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025RXST - MarketScreener
RXST FRAUD REMINDER: RxSight, Inc. Stock Drop Triggers - GlobeNewswire
Is RxSight Inc. a strong growth stockQuarterly Risk Review & High Return Trade Guides - mustnews.co.kr
RxSight to Present at Wells Fargo Healthcare Conference, Highlighting Vision Customization Tech - AInvest
Live market analysis of RxSight Inc.Market Volume Summary & Real-Time Price Movement Reports - Newser
Using portfolio simulators with RxSight Inc. includedGold Moves & Growth Focused Stock Pick Reports - Newser
Can RxSight Inc. sustain earnings growthWeekly Gains Summary & High Accuracy Swing Entry Alerts - thegnnews.com
RxSight, Inc. to Present at the Wells Fargo Healthcare Conference - 富途牛牛
RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit - PR Newswire
RxSight, Inc. (RXST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - MarketScreener
Class Action Filed Against RxSight, Inc. (RXST)September 22, 2025 Deadline to JoinContact The Gross Law Firm - PR Newswire
Lawsuit filed for Investors who lost money with shares of RxSight, Inc. (NASDAQ: RXST) - openPR.com
Shareholders who lost money on their RxSight, Inc. (NASDAQ: - GlobeNewswire
RXST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
RXSIGHT STOCK: Lose Money on Your RxSight, Inc. - GlobeNewswire
RxSight’s Earnings Call: Mixed Results Amid Growth and Challenges - MSN
RxSight, Inc. (NASDAQ:RXST) Q2 2025 Earnings Call Transcript - MSN
RXST INVESTOR NOTICE: RxSight, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - PR Newswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight - Morningstar
RxSight, Inc. and the Governance Crisis: Navigating Legal Storms and Shareholder Value Erosion - AInvest
RxSight, Inc. Faces Securities Lawsuit: Investors Advised to Contact Levi & Korsinsky - AInvest
RXSIGHT INVESTORS: Contact BFA Law about the RxSight, Inc. (RXST) Class Action before the September 22 Legal Deadline - Newsfile
Shareholders of RxSight, Inc. (RXST): Protect Your Rights Before September 22, 2025Contact Levi & Korsinsky - ACCESS Newswire
ROSEN, A LEADING NATIONAL FIRM, Encourages RxSight, Inc. - GlobeNewswire
Lost Money on RxSight, Inc. (RXST)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - GlobeNewswire
Class Action Lawsuit Filed: RxSight, Inc. (RXST)Join by September 22, 2025Contact Levi & Korsinsky - ACCESS Newswire
RXST COURT NOTICE: RxSight, Inc. Investors may have been - GlobeNewswire
RXST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that RxSight, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
RxSight, Inc. Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm Before September 22, 2025 to Discuss Your RightsRXST - PR Newswire
RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd - PR Newswire
Class Action Lawsuit Filed Against RxSight, Inc. (RXST)Recover LossesContact Levi & Korsinsky Before September 22, 2025 - ACCESS Newswire
RxSight, Inc. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your RightsRXST - 富途牛牛
Needham & Company LLC Cuts RxSight (NASDAQ:RXST) Price Target to $11.00 - Defense World
Investor Alert: Deadline Approaching to Join RxSight, Inc. (RXST) Class ActionContact Levi & Korsinsky - ACCESS Newswire
RXST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that RxSight, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Is RxSight Inc. building a consolidation baseFree Buy Low Sell High Stock Watch - Newser
Should you hold or exit RxSight Inc. nowStable Swing Setup with Safety Analysis - Newser
RXST Investors Have Opportunity To Lead RxSight, Inc. Securities Fraud Lawsuit - Barchart.com
RXST NEWS: Did RxSight, Inc. Mislead Investors? Contact BFA - GlobeNewswire
Automated trading signals detected on RxSight Inc.Secure Asset Flow and Trend Pattern Analysis - Newser
RxSight's Strategic Reinvention: Can International Expansion and Product Innovation Justify a Re-Rating? - AInvest
Class Action Filed Against RxSight, Inc. (RXST) Seeking Recovery for Investors – Contact Levi & Korsinsky - GlobeNewswire
Investors in RxSight, Inc. (RXST): Protect Your RightsContact Levi & Korsinsky Before September 22, 2025 - ACCESS Newswire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages RxSight, Inc. - GlobeNewswire
UBS Adjusts RxSight Price Target to $8 From $16, Maintains Neutral Rating - MarketScreener
RxSight stock price target cut by UBS to $8 on weak LDD placements - Investing.com
1.74%
0.24%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):